28 Jan 2020
Approved 505(b)(2) available for in-licensing:
CHP is pleased to announce the availability of an approved 505(b)(2) product in the cardiovascular space.  US rights only.
Asset has significant intellectual property rights.
This product is ideally suited for a company with a sales force calling on primary care providers and cardiologists.
Samples and inventory, supply and manufacturing agreements are in place.
See Our Opportunities